Literature DB >> 8760598

Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats.

K Miwa1, H Sahara, M Segawa, S Kinami, T Sato, I Miyazaki, T Hattori.   

Abstract

Esophageal adenocarcinoma arises from Barrett's esophagus, which is induced by gastro-esophageal reflux. This refluxate often contains duodenal contents, whose backflow triggers gastric carcinoma, suggesting the hypothesis that refluxed duodenal contents cause esophageal carcinoma. This study examines the role of duodenal and gastric reflux in the absence of exogenous carcinogens in esophageal carcinogenesis. Wistar male rats, 120 in all, each weighing approximately 250 g, were used. Three experimental procedures were performed to produce gastro-duodeno-esophageal reflux, duodeno-esophageal reflux and gastro-esophageal reflux, for comparison with 2 control procedures, Roux-en-Y reconstruction and a sham operation. The animals were fed a standard diet and were examined 50 weeks after surgery. While no carcinoma was found among the 16 gastro-esophageal-reflux, 11 Roux-en-Y and 12 sham-operation animals, 10 of the 12 animals with gastro-duodeno-esophageal reflux (83%) and 10 of the 13 with duodeno-esophageal reflux (77%) developed esophageal carcinoma. The difference between groups was significant (p < 0.001). Two animals with gastro-duodeno-esophageal reflux had esophageal double and triple carcinomas respectively. Of the 23 carcinomas, 16 were adenocarcinoma, 4 adenosquamous carcinoma, and 3 squamous-cell carcinoma. Adenocarcinoma developed from the columnar-lined epithelium near the esophago-jejunostoma, while adenosquamous and squamous-cell carcinoma arose from the squamous esophagitis. These observations demonstrate that refluxed duodenal contents per so are responsible for esophageal carcinogenesis.

Entities:  

Mesh:

Year:  1996        PMID: 8760598     DOI: 10.1002/(SICI)1097-0215(19960717)67:2<269::AID-IJC19>3.0.CO;2-6

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  60 in total

1.  Identification of Adenosquamous Carcinoma as a Rare Aggressive HER2-negative Subgroup of Esophageal/Gastroesophageal Junction Adenocarcinoma.

Authors:  Zhaohui Jin; Marie Holubek; William R Sukov; Christopher A Sattler; Anne E Wiktor; Robert B Jenkins; Tsung-Teh Wu; Harry H Yoon
Journal:  Am J Clin Oncol       Date:  2019-02       Impact factor: 2.339

2.  Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats.

Authors:  Koji Nishijima; Koichi Miwa; Tomoharu Miyashita; Shinichi Kinami; Itasu Ninomiya; Sachio Fushida; Takashi Fujimura; Takanori Hattori
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

3.  Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study.

Authors:  Michael B Cook; Sanford M Dawsey; Lena Diaw; Martin J Blaser; Guillermo I Perez-Perez; Christian C Abnet; Philip R Taylor; Demetrius Albanes; Jarmo Virtamo; Farin Kamangar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

4.  Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium.

Authors:  H Kazumori; S Ishihara; M A K Rumi; Y Kadowaki; Y Kinoshita
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

5.  Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett's esophagus.

Authors:  Elena Piazuelo; Carmelo Cebrián; Alfredo Escartín; Pilar Jiménez; Fernando Soteras; Javier Ortego; Angel Lanas
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

6.  Expression of Cdx2 in early GRCL of Barrett's esophagus induced in rats by duodenal reflux.

Authors:  Takeshi Tatsuta; Ken-Ichi Mukaisho; Hiroyuki Sugihara; Koichi Miwa; Tohru Tani; Takanori Hattori
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

7.  Expression of cyclooxygenase 2, microsomal prostaglandin E synthase 1, and EP receptors is increased in rat oesophageal squamous cell dysplasia and Barrett's metaplasia induced by duodenal contents reflux.

Authors:  T J Jang; S K Min; J D Bae; K H Jung; J I Lee; J R Kim; W S Ahn
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

8.  Coexistent multiple adenocarcinomas arising in Barrett's esophagus 23 years after total gastrectomy and esophageal small cell carcinoma.

Authors:  Tsuyoshi Noguchi; Shinsuke Takeno; Tetsuro Sato; Yuzo Uchida; Tsutomu Daa; Shigeo Yokoyama
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-06

9.  Validation of a rodent model of Barrett's esophagus using quantitative gene expression profiling.

Authors:  Daniel S Oh; Steven R DeMeester; Christy M Dunst; Ryutaro Mori; Bethany J Lehman; Hidekazu Kuramochi; Kathleen Danenberg; Peter Danenberg; Jeffrey A Hagen; Parakrama Chandrasoma; Tom R DeMeester
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

10.  Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a Pre-Barrett's esophagus setting.

Authors:  Tomoharu Miyashita; Furhawn A Shah; Guy Marti; Jiaai Wang; Todd Armstrong; Pramod Bonde; Michael K Gibson; Kiyoshi Yoshimura; Elizabeth A Montgomery; Mark D Duncan; Elizabeth M Jaffee; John W Harmon
Journal:  J Gastrointest Surg       Date:  2007-10-24       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.